SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022864
Filing Date
2020-05-07
Accepted
2020-05-07 16:14:32
Documents
64
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kzr-10q_20200331.htm   iXBRL 10-Q 2004849
2 EX-10.1 kzr-ex101_46.htm EX-10.1 151900
3 EX-10.2 kzr-ex102_47.htm EX-10.2 163443
4 EX-31.1 kzr-ex311_9.htm EX-31.1 19899
5 EX-31.2 kzr-ex312_6.htm EX-31.2 20043
6 EX-32.1 kzr-ex321_7.htm EX-32.1 9198
7 GRAPHIC gjccurr3nvnw000001.jpg GRAPHIC 32880
  Complete submission text file 0001564590-20-022864.txt   7320934

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA kzr-20200331.xsd EX-101.SCH 44706
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kzr-20200331_cal.xml EX-101.CAL 42735
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kzr-20200331_def.xml EX-101.DEF 116162
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE kzr-20200331_lab.xml EX-101.LAB 340662
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kzr-20200331_pre.xml EX-101.PRE 258601
27 EXTRACTED XBRL INSTANCE DOCUMENT kzr-10q_20200331_htm.xml XML 1329390
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Filer) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38542 | Film No.: 20856545
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences